ASX Announcement 30 October 2026 Cleansing notice under section 708A(5)(e) of the Corporations Act This notice is being given by Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (Company) under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations Act). The Company has today issued 74,021...
Cleansing Notice
Filed with ASX · · 1 page · English
Summary by 6ix AI
The notice confirms that the shares were issued without disclosure to investors and outlines compliance with relevant provisions of the Corporations Act. Additionally, it states that there is no excluded information that needs to be disclosed by the company as of the date of the notice.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Recce Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Recce Pharmaceuticals
- Application for quotation of securities - RCE
- Quarterly Activities/Appendix 4C Cash Flow Report
- License and Commercialisation Agreement in AUS/NZ for R327G
- Independent Review of Indonesian Phase 3 R327G Trial Data
- Notification regarding unquoted securities - RCE
Later from Recce Pharmaceuticals
All Recce Pharmaceuticals news releasesFollow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals